A Study of Subcutaneous HUMIRA (Adalimumab) Injection to Assess Adverse Events and Change in Disease Activity In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)

Peking University Third Hospital /ID# 242803, Beijing

Ruijin Hospital, Shanghai Jiaotong University School of Medicine /ID# 243213, Shanghai

Nanjing Drum Tower Hospital /ID# 243385, Nanjing

Zhejiang Provincial Hospital of Chinese Medicine /ID# 243443, Hangzhou

The second affiliated hospital of Zhejiang University school of medicine /ID# 242802, Hangzhou

Sir Run Run Shaw Hospital of Zhejiang University School of Medicine /ID# 242801, Hangzhou

Sun Yat-sen Memorial Hospital of Sun Yat-sen University /ID# 242798, Guangzhou

Nanfang Hospital of Southern Medical University /ID# 243386, Guangzhou

The Sixth Affiliated Hospital of Sun Yat-sen University /ID# 242799, Guangzhou

West China Hospital, Sichuan University /ID# 242804, Chengdu